NDAINTRAUTERINESOLUTION
Approved
Apr 1953
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 2d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SALPIX (acetrizoate sodium) is an intrauterine solution approved in 1953 as a contrast agent for diagnostic imaging procedures. It is administered directly into the uterine cavity to visualize reproductive anatomy during hysterosalpingography and related gynecological imaging studies. The drug works as a radiopaque contrast medium, allowing visualization of fallopian tube patency and uterine cavity morphology.
LOE Approaching
As a legacy product approaching loss of exclusivity with minimal current commercial infrastructure, career growth and team expansion are unlikely; roles are primarily focused on supply chain and compliance maintenance rather than innovation.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on SALPIX offers limited career advancement opportunities due to its status as a legacy diagnostic product with zero linked job openings and minimal commercial activity. Career progression typically involves transition to growth-stage products or lateral movement into manufacturing, regulatory, or compliance functions within the organization.
Supply Chain Manager
Worked on SALPIX at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.